Multi-infarct dementia: prevention and treatment
- PMID: 2059406
- DOI: 10.1097/00002093-199100520-00011
Multi-infarct dementia: prevention and treatment
Abstract
Multi-infarct dementia (MID) characteristically presents with an acute event followed by a stepwise and fluctuating downhill course. Progression is generally considered the consequence of recurrent stroke (Hachinski, 1983): the mainstay of treatment, therefore, is the prevention of further ischemic events.
Similar articles
-
Oxiracetam in the treatment of multi-infarct dementia.Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(5):673-82. doi: 10.1016/0278-5846(89)90054-7. Prog Neuropsychopharmacol Biol Psychiatry. 1989. PMID: 2781039
-
Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam.Int Psychogeriatr. 1992 Summer;4(1):25-44. doi: 10.1017/s1041610292000887. Int Psychogeriatr. 1992. PMID: 1391670 Clinical Trial.
-
Oxiracetam in the treatment of multi-infarct dementia and primary degenerative dementia.J Neuropsychiatry Clin Neurosci. 1989 Summer;1(3):249-52. doi: 10.1176/jnp.1.3.249. J Neuropsychiatry Clin Neurosci. 1989. PMID: 2521069 Clinical Trial.
-
Stroke in the elderly.Curr Opin Neurol. 1994 Feb;7(1):41-7. doi: 10.1097/00019052-199402000-00008. Curr Opin Neurol. 1994. PMID: 8173676 Review.
-
Vascular dementia: potential of antiplatelet agents in prevention.Eur Neurol. 2006;55(2):61-9. doi: 10.1159/000091981. Epub 2006 Mar 10. Eur Neurol. 2006. PMID: 16534208 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources